Swedish e-health company Trialbee has signed a professional service agreement with AstraZeneca for e-recruitment.

Trialbee enables AstraZeneca to recruit patients into specific clinical trials faster and more effectively reducing the clinical trial time. AstraZeneca can use Trialbee's services for e-recruitment globally, covering multiple therapeutic areas and study phases.

"Trialbee's direct-to-patient approach is very attractive since it enables patients to easily engage in clinical trials,” said Jenny Skogsberg, clinical development manager, AstraZeneca. “This follows the trend of patients increasingly searching for disease and treatment information online. Trialbee's solution helps patients to explore and access information about ongoing research and connects the stakeholders conducting clinical trials. Trialbee's solution has the potential to be used in many of our therapeutic areas and on many local markets going forward."

Trialbee is a software company specialized in clinical trial planning and management solutions. Trialbee provides global pharmaceutical companies a web-based solution for accurate and effective patient recruitment to clinical trials.